ETF Holdings Breakdown of IRON

Stock Name	Ironveld Plc
Ticker	IRON(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB0030426455
LEI	2138004LU52LQBNXG604

IRON institutional holdings

The following institutional investment holdings of IRON have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-20 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 4,065 USD 354,346 -3.2%

2025-10-20 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 21,954 USD 1,913,730

2025-10-20 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 21,954 USD 1,913,730

2025-10-20 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 14,533 USD 1,266,842

2025-10-20 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 90 USD 7,845

Total = 62,596 USD 5,456,493
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-20	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	4,065	USD 354,346 -3.2%
2025-10-20	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	21,954	USD 1,913,730
2025-10-20	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	21,954	USD 1,913,730
2025-10-20	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	14,533	USD 1,266,842
2025-10-20	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	90	USD 7,845
Total =	62,596	USD 5,456,493

News associated with IRON

Disc Medicine (NASDAQ:IRON) Price Target Raised to $90.00: Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective raised by Morgan Stanley from $85.00 to $90.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s price objective would indicate a potential upside of 54.69% from the company’s previous close. IRON has […] - 2025-08-20 02:46:48
Disc Medicine, Inc. (NASDAQ:IRON) Shares Bought by Arizona State Retirement System: Arizona State Retirement System grew its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 12.5% in the first quarter, HoldingsChannel reports. The fund owned 5,315 shares of the company’s stock after buying an additional 590 shares during the period. Arizona State Retirement System’s holdings in Disc Medicine were worth $264,000 as […] - 2025-07-23 05:44:47
Arizona State Retirement System Acquires 590 Shares of Disc Medicine, Inc. (NASDAQ:IRON): Arizona State Retirement System lifted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 12.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 5,315 shares of the company’s stock after acquiring an additional 590 shares during the period. Arizona State Retirement System’s holdings in Disc Medicine were worth […] - 2025-07-23 05:08:54
Disc Medicine To Seek FDA Approval For Bitopertin In EPP, A Painful Sunlight Sensitivity Disorder: (RTTNews) - Disc Medicine Inc. (IRON) is planning to submit a New Drug Application for its investigational oral drug Bitopertin in Erythropoietic Protoporphyria in October of this year. - 2025-07-22 08:18:48
Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright: HC Wainwright reaffirmed their buy rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a report issued on Thursday morning,Benzinga reports. The firm currently has a $118.00 price target on the stock. Several other equities research analysts have also recently commented on IRON. Morgan Stanley reaffirmed an “overweight” rating and issued a $85.00 […] - 2025-07-04 04:59:48
Disc Medicine (NASDAQ:IRON) Coverage Initiated by Analysts at Raymond James: Raymond James assumed coverage on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note published on Wednesday morning, MarketBeat.com reports. The brokerage issued a strong-buy rating and a $89.00 price target on the stock. A number of other research firms have also issued reports on IRON. Scotiabank raised their price target on […] - 2025-06-12 04:32:50
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages: Shares of Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) have earned a consensus recommendation of “Buy” from the eleven brokerages that are covering the firm, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year […] - 2025-06-03 02:36:48
Nuveen Asset Management LLC Decreases Position in Disc Medicine, Inc. (NASDAQ:IRON): Nuveen Asset Management LLC decreased its stake in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 47.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 50,121 shares of the company’s stock after selling 44,683 shares during the quarter. Nuveen Asset Management LLC’s holdings in Disc Medicine were worth $3,178,000 as of its […] - 2025-06-02 04:58:47
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by ProShare Advisors LLC: ProShare Advisors LLC lifted its stake in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 26.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,966 shares of the company’s stock after acquiring an additional 1,458 shares during the period. ProShare […] - 2025-05-28 04:54:55
Deutsche Bank AG Purchases 6,933 Shares of Disc Medicine, Inc. (NASDAQ:IRON): Deutsche Bank AG boosted its position in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 75.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,093 shares of the company’s stock after purchasing an additional 6,933 shares during the period. Deutsche Bank AG’s […] - 2025-05-27 05:16:55
Schonfeld Strategic Advisors LLC Has $311,000 Stock Position in Disc Medicine, Inc. (NASDAQ:IRON): Schonfeld Strategic Advisors LLC decreased its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 7.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,900 shares of the company’s stock after selling 381 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Disc Medicine were worth $311,000 as of its […] - 2025-05-13 05:38:52
Disc Medicine, Inc. (NASDAQ:IRON) Receives $93.80 Average Target Price from Analysts: Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has received a consensus recommendation of “Buy” from the eleven research firms that are covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 month price […] - 2025-05-12 02:40:44
Sterling Capital Management LLC Boosts Stake in Disc Medicine, Inc. (NASDAQ:IRON): Sterling Capital Management LLC boosted its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 798.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 566 shares of the company’s stock after acquiring an additional 503 shares during the quarter. Sterling Capital Management LLC’s […] - 2025-04-25 06:10:48
Raymond James Financial Inc. Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON): Raymond James Financial Inc. acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 88,002 shares of the company’s stock, valued at approximately $5,579,000. Raymond James Financial Inc. owned 0.30% […] - 2025-04-25 05:28:48
Renaissance Technologies LLC Takes Position in Disc Medicine, Inc. (NASDAQ:IRON): Renaissance Technologies LLC purchased a new position in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 86,420 shares of the company’s stock, valued at approximately $5,479,000. Several other large investors have also recently made changes […] - 2025-04-21 05:52:45
Intech Investment Management LLC Increases Stock Position in Disc Medicine, Inc. (NASDAQ:IRON): Intech Investment Management LLC boosted its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 69.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,890 shares of the company’s stock after purchasing an additional 3,243 shares during the […] - 2025-03-25 06:29:03
Disc Medicine, Inc. (NASDAQ:IRON) Director Sells $2,142,217.12 in Stock: Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) Director Mona Ashiya sold 39,656 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $54.02, for a total value of $2,142,217.12. Following the sale, the director now owns 188,981 shares of the company’s […] - 2025-03-24 06:04:53
Disc Medicine, Inc. (NASDAQ:IRON) Director Mona Ashiya Sells 10,011 Shares: Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) Director Mona Ashiya sold 10,011 shares of the company’s stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of $54.00, for a total transaction of $540,594.00. Following the completion of the sale, the director now directly owns 187,297 […] - 2025-03-24 06:04:53
Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says: Disc Medicine (NASDAQ:IRON – Get Free Report) had its target price increased by analysts at Cantor Fitzgerald from $99.00 to $132.00 in a note issued to investors on Tuesday, MarketBeat.com reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 145.63% from the stock’s […] - 2025-03-20 06:28:53
Disc Medicine, Inc. (NASDAQ:IRON) Shares Bought by Victory Capital Management Inc.: Victory Capital Management Inc. raised its holdings in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 7.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 236,244 shares of the company’s stock after acquiring an additional 16,230 shares during the quarter. Victory Capital Management […] - 2025-03-13 06:32:54
Bleakley Financial Group LLC Acquires Shares of 7,667 Disc Medicine, Inc. (NASDAQ:IRON): Bleakley Financial Group LLC acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,667 shares of the company’s stock, valued at approximately $486,000. Several other institutional investors have also […] - 2025-02-11 06:46:53

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.